Penederm Inc has received approval in the UK to market its Avita(retinoic acid) cream and gel products for the treatment of acne. The UK will act as the rapporteur country for the rest of the European Union through the European Mutual Recognition Process.
This is Penederm's first prescription product containing its TopiCare delivery compounds which are liquid polymers designed to release and hold drugs in the upper layers of the skin. Avita products were given approval by the US Food and Drug Administration in January this year, and a launch is planned for the third quarter of 1997.
- Meanwhile, Dermik Laboratories has launched its antiacne product Klaron lotion 10% (sodium sulfacetamide) onto the US market. The alcohol-free, water-based lotion has been shown to treat acne effectively, while "keeping female patients who experience dry or sensitive skin in mind." According to a spokesman for the company, the average wholesale price for a 2oz bottle is $27.18, and $23.10 direct.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze